Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Aβ42 oligomers disrupt calcium homeostasis via Piezo1 and induce neurotoxicity in differentiated SH-SY5Y cells 2026-10-29
  2. Endocannabinnoids innervate Circadian mechinary mitigating neuroinflammation, amyloidogenesis and cognition phenotypic to AD 2026-10-29
  3. Repeated VU0155069 Treatment Is Associated with Region- and Pathological Stage-Specific Dendritic Spine Remodeling in Female 3xTg-AD Mice 2026-10-27

Studies

287 studies carry this tag.

Date range

1983 to 2026

Top journals

  • The Journal of neuroscience : the official journal of the Society for Neuroscience 17
  • Nature neuroscience 10
  • Neuron 10
  • bioRxiv 10
  • Nature 8

137 journals in all.

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. PLD3 affects axonal spheroids and network defects in Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Nature 2022-11-30 Digital health tools

    The precise mechanisms that lead to cognitive decline in Alzheimer's disease are unknown.

  2. The Transcranial Light Therapy Improves Synaptic Plasticity in the Alzheimer's Disease Mouse Model

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Brain sciences 2022-09-21 Disease mechanisms

    Alzheimer's disease (AD) is the main cause of dementia worldwide.

  3. CRISPR/dCas9-Dnmt3a-mediated targeted DNA methylation of APP rescues brain pathology in a mouse model of Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Translational neurodegeneration 2022-09-15 Biomarkers

    These results suggest that the targeted methylation of APP via dCas9-Dnmt3a treatment can be a potential therapeutic strategy for AD.

  4. LATE-NC aggravates GVD-mediated necroptosis in Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Acta neuropathologica communications 2022-09-03 Brain tissue and pathology

    Recently, we found that all proteins required for necroptosis execution, a previously defined programmed form of neuronal cell death, are present in GVD, such as the phosphorylated necroptosis executioner mixed-lineage kinase domain-like protein (pMLKL).

  5. Microglial large extracellular vesicles propagate early synaptic dysfunction in Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Brain : a journal of neurology 2022-08-27 Disease mechanisms

    Synaptic dysfunction is an early mechanism in Alzheimer's disease that involves progressively larger areas of the brain over time.

  6. Role of Aβ in Alzheimer's-related synaptic dysfunction

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Frontiers in cell and developmental biology 2022-08-26 Disease mechanisms

    Synaptic dysfunction is closely related to Alzheimer's disease (AD) which is also recognized as synaptic disorder. β-amyloid (Aβ) is one of the main pathogenic factors in AD, which disrupts synaptic plasticity and mediates the synaptic toxicity through different mechanisms.

  7. The role of genetic risk factors of Alzheimer's disease in synaptic dysfunction

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Seminars in cell & developmental biology 2022-07-30 Disease mechanisms

    Alzheimer's disease (AD) is a neurodegenerative disease characterized by the progressive deterioration of cognitive functions.

  8. Trans-Anethole Alleviates Trimethyltin Chloride-Induced Impairments in Long-Term Potentiation

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Pharmaceutics 2022-07-06 Disease mechanisms

    Trans-anethole is an aromatic compound that has been studied for its anti-inflammation, anticonvulsant, antinociceptive, and anticancer effects.

  9. Exosomes derived from bone-marrow mesenchymal stem cells alleviate cognitive decline in AD-like mice by improving BDNF-related neuropathology

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Journal of neuroinflammation 2022-02-07 Biomarkers

    Lateral ventricle administration, but not caudal vein injection of BMSC-exos improved AD-like behaviors in the STZ-injected mouse model, as indicated by the increased number of rearing, increased frequency to the central area, and increased duration and distance traveled in the central area in the OFT, and improved preference index of the novel object in the NOR.

  10. Hippocampus and its involvement in Alzheimer's disease: a review

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. 3 Biotech 2022-02-01 Prevention trials

    Hippocampus is the significant component of the limbic lobe, which is further subdivided into the dentate gyrus and parts of Cornu Ammonis.

  11. Brain-derived neurotrophic factor in Alzheimer's disease and its pharmaceutical potential

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Translational neurodegeneration 2022-01-28 Disease mechanisms

    Synaptic abnormalities are a cardinal feature of Alzheimer's disease (AD) that are known to arise as the disease progresses.

  12. CaMKIIβ knockdown decreases store-operated calcium entry in hippocampal dendritic spines

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. IBRO neuroscience reports 2022-01-10 Disease mechanisms

    Calcium/calmodulin-dependent protein kinase II (CaMKII) and neuronal store-operated calcium entry (nSOCE) have been implicated in the development of Alzheimer's disease (AD). nSOCE is involved in regulation of dendritic spine shape, particularly in stability of mushroom spines that play role in formation of strong synapses.

  13. Nr4a2 Transcription Factor in Hippocampal Synaptic Plasticity, Memory and Cognitive Dysfunction: A Perspective Review

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Frontiers in molecular neuroscience 2021-11-22 Disease mechanisms

    Long-lasting changes of synaptic efficacy are largely mediated by activity-induced gene transcription and are essential for neuronal plasticity and memory.

  14. Noncognitive species-typical and home-cage behavioral alterations in conditional presenilin 1/presenilin 2 double knockout mice

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Behavioural brain research 2021-11-07 Risk genes beyond APOE

    Impairments in activities of daily living (ADL) are common clinical symptoms of human Alzheimer's disease (AD).

  15. Loss of TDP-43 function underlies hippocampal and cortical synaptic deficits in TDP-43 proteinopathies

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Molecular psychiatry 2021-10-25 Disease mechanisms

    TDP-43 proteinopathy is linked to neurodegenerative diseases that feature synaptic loss in the cortex and hippocampus, although it remains unclear how TDP-43 regulates mature synapses.

  16. Rho Signaling in Synaptic Plasticity, Memory, and Brain Disorders

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Frontiers in cell and developmental biology 2021-10-04 Disease mechanisms

    Memory impairments are associated with many brain disorders such as autism, Alzheimer's disease, and depression.

  17. Neurogranin and Neuronal Pentraxin Receptor as Synaptic Dysfunction Biomarkers in Alzheimer's Disease

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Journal of clinical medicine 2021-10-02 Disease mechanisms

    The CSF level of Ng was significantly higher, whereas the NPTXR was significantly lower in the AD patients than in cognitively healthy controls.

  18. LIM-Kinases in Synaptic Plasticity, Memory, and Brain Diseases

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Cells 2021-08-13 Disease mechanisms

    Learning and memory require structural and functional modifications of synaptic connections, and synaptic deficits are believed to underlie many brain disorders.

  19. Modeling Sporadic Alzheimer's Disease in Human Brain Organoids under Serum Exposure

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2021-08-02 Digital health tools

    Alzheimer's disease (AD) is a progressive neurodegenerative disease with no cure.

  20. Comprehensive Evaluation of the 5XFAD Mouse Model for Preclinical Testing Applications: A MODEL-AD Study

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Frontiers in aging neuroscience 2021-07-23 Genetics

    The ability to investigate therapeutic interventions in animal models of neurodegenerative diseases depends on extensive characterization of the model(s) being used.

  21. Mesenchymal stem cell-derived extracellular vesicles ameliorate Alzheimer's disease-like phenotypes in a preclinical mouse model

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Theranostics 2021-07-13 Biomarkers

    The data revealed that 5XFAD mice that received hMSC-EV treatment behaved significantly better in cognitive tests than saline treated 5XFAD mice, with no significant change between EV-treated 5XFAD mice and NT mice.

  22. Synaptic Plasticity and Oscillations in Alzheimer's Disease: A Complex Picture of a Multifaceted Disease

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Frontiers in molecular neuroscience 2021-06-17 Disease mechanisms

    Brain plasticity is widely accepted as the core neurophysiological basis of memory and is generally defined by activity-dependent changes in synaptic efficacy, such as long-term potentiation (LTP) and long-term depression (LTD).

  23. Astrocytes and Adenosine A2A Receptors: Active Players in Alzheimer's Disease

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Frontiers in neuroscience 2021-05-13 Disease mechanisms

    Astrocytes, through their numerous processes, establish a bidirectional communication with neurons that is crucial to regulate synaptic plasticity, the purported neurophysiological basis of memory.

  24. VEGF counteracts amyloid-β-induced synaptic dysfunction

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Cell reports 2021-05-11 Disease mechanisms

    The vascular endothelial growth factor (VEGF) pathway regulates key processes in synapse function, which are disrupted in early stages of Alzheimer's disease (AD) by toxic-soluble amyloid-beta oligomers (Aβo).

  25. Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Molecular psychiatry 2021-04-19 Genetics

    The prefrontal cortex (PFC) serves as the chief executive officer of the brain, controlling the highest level cognitive and emotional processes.

  26. Dopamine: The Neuromodulator of Long-Term Synaptic Plasticity, Reward and Movement Control

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Cells 2021-03-26 Disease mechanisms

    Dopamine (DA) is a key neurotransmitter involved in multiple physiological functions including motor control, modulation of affective and emotional states, reward mechanisms, reinforcement of behavior, and selected higher cognitive functions.

  27. Cognitive reserve and Alzheimer's biological continuum: clues for prediction and prevention of dementia

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Minerva medica 2021-03-12 Risk factors

    Cognitive reserve is originally an epidemiological concept that encompasses individual abilities to cope with changes.

  28. High levels of 27-hydroxycholesterol results in synaptic plasticity alterations in the hippocampus

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Scientific reports 2021-02-12 Disease mechanisms

    Alterations in brain cholesterol homeostasis in midlife are correlated with a higher risk of developing Alzheimer's disease (AD).

  29. GABAergic dysfunction, neural network hyperactivity and memory impairments in human aging and Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Seminars in cell & developmental biology 2021-02-09 Digital health tools

    In this review, we focus on the potential role of the γ-aminobutyric acidergic (GABAergic) system in age-related episodic memory impairments in humans, with a particular focus on Alzheimer's disease (AD).

  30. Selective coactivation of α7- and α4β2-nicotinic acetylcholine receptors reverses beta-amyloid-induced synaptic dysfunction

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. The Journal of biological chemistry 2021-02-09 Disease mechanisms

    Beta-amyloid (Aβ) has been recognized as an early trigger in the pathogenesis of Alzheimer's disease (AD) leading to synaptic and cognitive impairments.

  31. EGB761 ameliorates chronic cerebral hypoperfusion-induced cognitive dysfunction and synaptic plasticity impairment

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Aging 2021-02-03 Disease mechanisms

    Chronic cerebral hypoperfusion (CCH) may lead to the cognitive dysfunction, but the underlying mechanisms are unclear.

  32. Clusterin secreted from astrocyte promotes excitatory synaptic transmission and ameliorates Alzheimer's disease neuropathology

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Molecular neurodegeneration 2021-01-31 Treatments

    We identify Clu as an astrocyte-derived synaptogenic and anti-amyloid factor; the combination of these activities may influence the progression of late-onset AD.

  33. Role of phosphodiesterases in the pathophysiology of neurodevelopmental disorders

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Molecular psychiatry 2021-01-07 Down syndrome and Alzheimer's

    Phosphodiesterases (PDEs) are enzymes involved in the homeostasis of both cAMP and cGMP.

  34. Inhibition of miR-96-5p May Reduce Aβ42/Aβ40 Ratio via Regulating ATP-binding cassette transporter A1

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Journal of Alzheimer's disease : JAD 2021 Biomarkers

    The expression of ABCA1 was significantly downregulated in AD models at both mRNA and protein levels.

  35. Neurotrophic Treatment Initiated During Early Postnatal Development Prevents the Alzheimer-Like Behavior and Synaptic Dysfunction

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Journal of Alzheimer's disease : JAD 2021 Disease mechanisms

    P021 treatment during early development prevented cognitive impairment and increased expressions of pCREB and BDNF that activated downstream various signaling cascades such as PLC/PKC, MEK/ERK and PI3K/Akt, and ameliorated synaptic protein deficit in 4-month-old 3xTg-AD mice.

  36. REDD1 Is Involved in Amyloid β-Induced Synaptic Dysfunction and Memory Impairment

    ✓ Peer-reviewed alzhub usefulness score 39 out of 100. International journal of molecular sciences 2020-12-13 Disease mechanisms

    Alzheimer's disease (AD) is a neurodegenerative disease characterized by neurological dysfunction, including memory impairment, attributed to the accumulation of amyloid β (Aβ) in the brain.

  37. KALRN: A central regulator of synaptic function and synaptopathies

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Gene 2020-11-13 Disease mechanisms

    The synaptic regulator, kalirin, plays a key role in synaptic plasticity and formation of dendritic arbors and spines.

  38. The Role of ADF/Cofilin in Synaptic Physiology and Alzheimer's Disease

    ✓ Peer-reviewed alzhub usefulness score 39 out of 100. Frontiers in cell and developmental biology 2020-11-12 Disease mechanisms

    Actin-depolymerization factor (ADF)/cofilin, a family of actin-binding proteins, are critical for the regulation of actin reorganization in response to various signals.

  39. Neuronal Protein Farnesylation Regulates Hippocampal Synaptic Plasticity and Cognitive Function

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Molecular neurobiology 2020-10-24 Disease mechanisms

    Protein prenylation is a post-translational lipid modification that governs a variety of important cellular signaling pathways, including those regulating synaptic functions and cognition in the nervous system.

  40. Neurotrophic Factor BDNF, Physiological Functions and Therapeutic Potential in Depression, Neurodegeneration and Brain Cancer

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. International journal of molecular sciences 2020-10-21 Risk factors

    Brain-derived neurotrophic factor (BDNF) is one of the most distributed and extensively studied neurotrophins in the mammalian brain.

  41. The two faces of synaptic failure in AppNL-G-F knock-in mice

    ✓ Peer-reviewed alzhub usefulness score 39 out of 100. Alzheimer's research & therapy 2020-08-24 Disease mechanisms

    We found a beginning synaptic impairment (LTP deficit) at 3-4 months in the prefrontal cortex of AppNL-G-F mice that is further aggravated and extended to the hippocampus at 6-8 months.

  42. GABAergic Inhibitory Interneuron Deficits in Alzheimer's Disease: Implications for Treatment

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Frontiers in neuroscience 2020-06-30 Digital health tools

    Alzheimer's disease (AD) is a neurodegenerative disorder characterized clinically by severe cognitive deficits and pathologically by amyloid plaques, neuronal loss, and neurofibrillary tangles.

  43. TRIM32 Deficiency Impairs Synaptic Plasticity by Excitatory-Inhibitory Imbalance via Notch Pathway

    ✓ Peer-reviewed alzhub usefulness score 39 out of 100. Cerebral cortex (New York, N.Y. : 1991) 2020-06-30 Disease mechanisms

    Synaptic plasticity is the neural basis of physiological processes involved in learning and memory.

  44. Human iPSC-Derived Hippocampal Spheroids: An Innovative Tool for Stratifying Alzheimer Disease Patient-Specific Cellular Phenotypes and Developing Therapies

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Stem cell reports 2020-06-25 Biomarkers

    The hippocampus is important for memory formation and is severely affected in the brain with Alzheimer disease (AD).

  45. Dendritic Spine and Synaptic Plasticity in Alzheimer's Disease: A Focus on MicroRNA

    ✓ Peer-reviewed alzhub usefulness score 39 out of 100. Frontiers in cell and developmental biology 2020-05-05 Disease mechanisms

    Dendrites and dendritic spines are dynamic structures with pivotal roles in brain connectivity and have been recognized as the locus of long-term synaptic plasticity related to cognitive processes such as learning and memory.

  46. The parahippocampal gyrus-orbitofrontal cortex (PHG-OFC) circuit in humans is homologous to the postrhinal cortex (POR)-ventral lateral orbitofrontal cortex (vlOFC) circuit in rodents.

  47. Synaptic plasticity in Alzheimer's disease and healthy aging

    ✓ Peer-reviewed alzhub usefulness score 39 out of 100. Reviews in the neurosciences 2020-04-28 Disease mechanisms

    The strength and efficiency of synaptic connections are affected by the environment or the experience of the individual.

  48. Spinosin Attenuates Alzheimer's Disease-Associated Synaptic Dysfunction via Regulation of Plasmin Activity

    ✓ Peer-reviewed alzhub usefulness score 39 out of 100. Biomolecules & therapeutics 2020-03-01 Disease mechanisms

    Hippocampal synaptic dysfunction is a hallmark of Alzheimer's disease (AD).

  49. Benzothiazole amphiphiles promote RasGRF1-associated dendritic spine formation in human stem cell-derived neurons

    ✓ Peer-reviewed alzhub usefulness score 39 out of 100. FEBS open bio 2020-01-30 Disease mechanisms

    Synaptic dysfunction has been implicated as an early cause of cognitive decline in neurodegenerative diseases (NDDs) such as Alzheimer's disease (AD).

  50. Dendritic Spines in Alzheimer's Disease: How the Actin Cytoskeleton Contributes to Synaptic Failure

    ✓ Peer-reviewed alzhub usefulness score 39 out of 100. International journal of molecular sciences 2020-01-30 Disease mechanisms

    Alzheimer's disease (AD) is a neurodegenerative disorder characterized by Aβ-driven synaptic dysfunction in the early phases of pathogenesis.

From across this tag

8 of the 287 studies in this tag, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 8. The same 8 appear here every time.

All topic tags with their study counts